<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>MAOIs - Complete Profile</title>
    <link rel="stylesheet" href="/style.css">
</head>

<body>
  <body class="
  
  
  
  ">
    <header class="page-header">
  <div class="container">
    <div class="page-header__content">
      <div class="logo-container">
        <a href="/" class="site-title">Dyo's Dubious Domain</a>
      </div>
      
      <nav>
        <ul role="list" class="nav-list flex-group">
          <li>
            <a href="/">Home</a>
          </li>
          <li>
            <a href="/dyos-domain/">Dyo's Domain</a>
          </li>
          <li>
            <a href="/about/">About</a>
          </li>
          <li>
            <a href="/profile/">My Profile</a>
          </li>
         
        </ul>
      </nav>
    </div>
    
    <!-- Search Bar - Now underneath header -->
    <div class="search-container">
      <input type="text" id="search-input" placeholder="Search substances..." class="search-input" />
      <div id="search-results" class="search-results" style="display: none;"></div>
    </div>
  </div>
</header>

    <main>
      
<div class="substance-profile-header">
  <div class="container">
    <nav class="breadcrumb">
      <a href="/dyos-domain/">Dyo's Domain</a> ‚Üí <a href="/dyos-domain/nootropics/">Nootropics</a> ‚Üí <span>MAOIs</span>
    </nav>
    
    <div class="substance-hero">
      <div class="substance-info">
        <h1>‚öóÔ∏è MAOIs</h1>
        <h2 class="chemical-name">Monoamine Oxidase Inhibitors</h2>
          <!-- Add to Profile Button -->
        <button id="add-to-profile-btn" class="add-to-profile-btn not-in-profile" 
                data-substance="MAOIs" 
                data-category="Nootropics" 
                data-chemical="Monoamine Oxidase Inhibitors">
          + Add to My Profile
        </button>
        
        <div class="alternative-names">
          <h3>Alternative Names & Slang</h3>
          <div class="names-grid">
            <div class="name-category">
              <h4>Pharmaceutical MAOIs</h4>
              <span>Nardil</span> ‚Ä¢ <span>Parnate</span> ‚Ä¢ <span>Marplan</span> ‚Ä¢ <span>Emsam</span> ‚Ä¢ <span>Azilect</span>
            </div>
            <div class="name-category">
              <h4>Natural Sources</h4>
              <span>Syrian Rue</span> ‚Ä¢ <span>Ayahuasca Vine</span> ‚Ä¢ <span>Passionflower</span> ‚Ä¢ <span>Yohimbe</span>
            </div>
            <div class="name-category">
              <h4>Chemical Names</h4>
              <span>Phenelzine</span> ‚Ä¢ <span>Tranylcypromine</span> ‚Ä¢ <span>Selegiline</span> ‚Ä¢ <span>Harmaline</span>
            </div>
            <div class="name-category">
              <h4>Street/Community Names</h4>
              <span>MAO Inhibitors</span> ‚Ä¢ <span>Antidepressants</span> ‚Ä¢ <span>Rue Seeds</span> ‚Ä¢ <span>Caapi</span>
            </div>
          </div>
        </div>
        
        <div class="substance-meta-large">
          <span class="category nootropic">Nootropic</span>
          <span class="legal-status prescription">Prescription</span>
          <span class="duration long">Days-Weeks</span>
          <span class="medical">Medical Use</span>
          <span class="extreme">Extreme Interactions</span>
        </div>
      </div>
      
      <div class="substance-visual">
        <div class="substance-image">
          <img src="/assets/substances/maois.jpg" alt="MAOI medications and natural sources" class="substance-photo">
        </div>
        <div class="molecule-structure">
          <div class="structure-placeholder">
            <p>üß¨ Various Structures</p>
            <p>MAO-A & MAO-B Inhibition</p>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>

<div class="container">
  
  <div class="profile-grid">
    
    <div class="profile-section identification">
      <h3>üîç Physical Identification</h3>
      <div class="identification-info">
        <div class="pure-form">
          <h4>Pharmaceutical MAOIs</h4>
          <ul>
            <li><strong>Nardil (Phenelzine):</strong> Orange/yellow tablets, 15mg</li>
            <li><strong>Parnate (Tranylcypromine):</strong> Red tablets, 10mg</li>
            <li><strong>Marplan (Isocarboxazid):</strong> Pink tablets, 10mg</li>
            <li><strong>Emsam (Selegiline):</strong> Transdermal patches, various strengths</li>
            <li><strong>Azilect (Rasagiline):</strong> White tablets, 0.5mg/1mg</li>
          </ul>
        </div>
        
        <div class="street-forms">
          <h4>Natural MAOI Sources</h4>
          <ul>
            <li><strong>Syrian Rue Seeds:</strong> Small, angular, dark brown seeds (Peganum harmala)</li>
            <li><strong>Banisteriopsis Caapi:</strong> Woody vine pieces, brown bark strips</li>
            <li><strong>Passionflower:</strong> Dried leaves, mild MAOI activity</li>
            <li><strong>Tobacco:</strong> Contains natural MAOI compounds</li>
            <li><strong>Extracts:</strong> Concentrated harmine/harmaline preparations</li>
          </ul>
        </div>
        
        <div class="adulterants-warning">
          <h4>‚ö†Ô∏è Identification & Purity Issues</h4>
          <p><strong>Pharmaceuticals:</strong> Legitimate prescriptions are precisely dosed and pure</p>
          <p><strong>Natural sources:</strong> Variable MAOI content, identification critical for safety</p>
          <p><strong>Extracts:</strong> Purity and concentration vary dramatically</p>
          <p><strong>Critical:</strong> Misidentification of plants can be fatal</p>
        </div>
      </div>
    </div>
    
    <div class="profile-section dosage">
      <h3>üíä Dosage Guidelines</h3>
      <div class="dosage-chart">
        <div class="dose-range threshold">
          <span class="range-label">Therapeutic (Pharma)</span>
          <span class="dose-amount">15-30mg/day</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range light">
          <span class="range-label">Standard (Pharma)</span>
          <span class="dose-amount">30-60mg/day</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range common">
          <span class="range-label">High Therapeutic</span>
          <span class="dose-amount">60-90mg/day</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range strong">
          <span class="range-label">Natural Sources</span>
          <span class="dose-amount">Variable</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range heavy">
          <span class="range-label">Dangerous</span>
          <span class="dose-amount">Overdose Risk</span>
          <div class="dose-bar"></div>
        </div>
      </div>
      
      <div class="dosage-details">
        <h4>Specific MAOI Dosing</h4>
        <ul>
          <li><strong>Phenelzine (Nardil):</strong> 15mg 2-3x daily, up to 90mg/day maximum</li>
          <li><strong>Tranylcypromine (Parnate):</strong> 10mg 2x daily, up to 60mg/day</li>
          <li><strong>Selegiline (Emsam):</strong> 6-12mg/day transdermal patch</li>
          <li><strong>Syrian Rue:</strong> 2-5g seeds (highly variable harmine content)</li>
          <li><strong>B. Caapi:</strong> 50-150g vine in ayahuasca preparations</li>
          <li><strong>Medical supervision:</strong> All pharmaceutical dosing requires medical oversight</li>
        </ul>
      </div>
      
      <p class="dosage-note"><strong>EXTREME WARNING:</strong> MAOIs require 2-week washout periods and strict dietary restrictions. Overdose can be fatal. Never combine with other antidepressants or stimulants.</p>
    </div>

    <div class="profile-section effects">
      <h3>‚ú® Effects Profile</h3>
      
      <div class="effects-timeline">
        <h4>Timeline (Pharmaceutical)</h4>
        <div class="timeline-item">
          <span class="time">Day 1-7</span>
          <span class="effect">Initial - side effects begin, no antidepressant benefit yet</span>
        </div>
        <div class="timeline-item">
          <span class="time">Week 2-4</span>
          <span class="effect">Onset - gradual mood improvement, energy increase</span>
        </div>
        <div class="timeline-item">
          <span class="time">Week 4-8</span>
          <span class="effect">Peak - full antidepressant effects, stabilization</span>
        </div>
        <div class="timeline-item">
          <span class="time">Ongoing</span>
          <span class="effect">Maintenance - continued benefits with dietary restrictions</span>
        </div>
        <div class="timeline-item">
          <span class="time">Discontinuation</span>
          <span class="effect">2-week washout required before other medications</span>
        </div>
      </div>

      <div class="effects-categories">
        <div class="effect-category positive">
          <h4>‚úÖ Therapeutic Effects</h4>
          <ul>
            <li>Profound relief from treatment-resistant depression</li>
            <li>Increased energy and motivation</li>
            <li>Enhanced social confidence</li>
            <li>Improved sleep quality (initially)</li>
            <li>Increased appetite and weight gain</li>
            <li>Reduced anxiety and panic attacks</li>
            <li>Enhanced emotional responsiveness</li>
          </ul>
        </div>
        
        <div class="effect-category negative">
          <h4>‚ùå Side Effects & Risks</h4>
          <ul>
            <li>Hypertensive crisis from dietary indiscretions</li>
            <li>Orthostatic hypotension (blood pressure drops)</li>
            <li>Sexual dysfunction</li>
            <li>Weight gain (often significant)</li>
            <li>Sleep disturbances and insomnia</li>
            <li>Daytime sedation and fatigue</li>
            <li>Serotonin syndrome with drug interactions</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section pharmacology">
      <h3>üß† Pharmacology & Neuroscience</h3>
      <div class="pharma-details">
        <h4>Primary Mechanism of Action</h4>
        <p>MAOIs work by irreversibly (or reversibly, depending on type) binding to and inhibiting monoamine oxidase enzymes (MAO-A and MAO-B) that normally break down neurotransmitters. This leads to increased levels of serotonin, norepinephrine, and dopamine in synaptic clefts, creating antidepressant effects but also dangerous interactions with tyramine-containing foods and other drugs.</p>
        
        <h4>Detailed Enzyme Pharmacology</h4>
        <div class="receptor-table">
          <div class="receptor-row">
            <span class="receptor-name"><strong>MAO-A enzyme</strong></span>
            <span class="affinity">Primary target of most antidepressant MAOIs</span>
            <span class="function">Breaks down serotonin, norepinephrine, tyramine</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>MAO-B enzyme</strong></span>
            <span class="affinity">Targeted by selegiline, rasagiline</span>
            <span class="function">Breaks down dopamine, phenethylamine</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>Serotonin accumulation</strong></span>
            <span class="affinity">Dramatic increase in synaptic 5-HT</span>
            <span class="function">Primary antidepressant mechanism</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>Norepinephrine accumulation</strong></span>
            <span class="affinity">Increased synaptic noradrenaline</span>
            <span class="function">Energy, motivation, blood pressure effects</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>Dopamine accumulation</strong></span>
            <span class="affinity">Modest increase in dopaminergic activity</span>
            <span class="function">Motivation, reward, movement</span>
          </div>
        </div>

        <h4>Metabolism & Pharmacokinetics</h4>
        <div class="metabolism-details">
          <p><strong>Irreversible inhibition:</strong> Most MAOIs permanently bind to enzymes</p>
          <p><strong>Enzyme regeneration:</strong> Body must synthesize new MAO enzymes (2-3 weeks)</p>
          <p><strong>Half-life varies:</strong> 2-4 hours for drug, but effects last weeks</p>
          <p><strong>Hepatic metabolism:</strong> Processed by liver enzymes</p>
          <p><strong>Washout period:</strong> 2 weeks minimum before other antidepressants</p>
          <p><strong>Food interactions:</strong> Tyramine cannot be metabolized, causes hypertensive crisis</p>
        </div>

        <h4>Tyramine Crisis Mechanism</h4>
        <div class="neurotoxicity-info">
          <p><strong>Normal process:</strong> MAO-A breaks down dietary tyramine in gut and liver</p>
          <p><strong>MAOI blockade:</strong> Tyramine accumulates and reaches systemic circulation</p>
          <p><strong>Norepinephrine release:</strong> Tyramine triggers massive NE release</p>
          <p><strong>Hypertensive crisis:</strong> Blood pressure spikes to dangerous levels</p>
          <p><strong>Potential outcomes:</strong> Stroke, heart attack, intracranial hemorrhage</p>
        </div>

        <h4>Unique Pharmacological Properties</h4>
        <ul>
          <li><strong>Irreversible binding:</strong> Effects persist long after drug clearance</li>
          <li><strong>Non-selective action:</strong> Affects multiple neurotransmitter systems</li>
          <li><strong>Dietary dependence:</strong> Effectiveness tied to food restrictions</li>
          <li><strong>Drug interaction severity:</strong> Potentially fatal combinations common</li>
          <li><strong>Last-line treatment:</strong> Reserved for treatment-resistant cases</li>
          <li><strong>Natural occurrence:</strong> Found in various plants used traditionally</li>
        </ul>
      </div>
    </div>

    <div class="profile-section safety">
      <h3>‚ö†Ô∏è Safety & Harm Reduction</h3>
      
      <div class="safety-grid">
        <div class="safety-item critical">
          <h4>üö® LIFE-THREATENING RISKS</h4>
          <ul>
            <li><strong>Hypertensive crisis:</strong> Tyramine-rich foods can cause fatal blood pressure spikes</li>
            <li><strong>Serotonin syndrome:</strong> Potentially fatal with SSRIs, MDMA, tramadol</li>
            <li><strong>Drug interactions:</strong> Dangerous with most psychiatric medications</li>
            <li><strong>Stimulant combinations:</strong> Fatal with amphetamines, cocaine, caffeine</li>
            <li><strong>Anesthetic complications:</strong> Inform all medical providers of MAOI use</li>
          </ul>
        </div>
        
        <div class="safety-item precautions">
          <h4>üõ°Ô∏è Mandatory Precautions</h4>
          <ul>
            <li>Strict dietary restrictions - no aged, fermented, or cured foods</li>
            <li>Carry medical alert identification at all times</li>
            <li>Regular blood pressure monitoring</li>
            <li>2-week washout before any other antidepressants</li>
            <li>Inform all healthcare providers of MAOI use</li>
            <li>Emergency plan for hypertensive crisis</li>
          </ul>
        </div>
      </div>

      <div class="contraindications">
        <h4>üö´ Absolute Contraindications</h4>
        <p><strong>NEVER use if you have:</strong> Uncontrolled hypertension, heart disease, liver disease, pheochromocytoma, cerebrovascular disease, or if taking other antidepressants, stimulants, or numerous other medications. Requires extensive medical screening.</p>
      </div>
    </div>

    <div class="profile-section interactions">
      <h3>‚öóÔ∏è Drug Interactions</h3>
      
      <div class="interaction-levels">
        <div class="interaction dangerous">
          <h4>üî¥ FATAL COMBINATIONS</h4>
          <ul>
            <li><strong>SSRIs/SNRIs:</strong> Life-threatening serotonin syndrome</li>
            <li><strong>Stimulants:</strong> Hypertensive crisis, stroke, heart attack</li>
            <li><strong>MDMA/Ecstasy:</strong> Extreme hyperthermia, serotonin syndrome</li>
            <li><strong>Tramadol:</strong> Serotonin syndrome, seizures</li>
            <li><strong>Dextromethorphan:</strong> Serotonin syndrome</li>
            <li><strong>Tricyclic antidepressants:</strong> Severe interactions</li>
          </ul>
        </div>
        
        <div class="interaction risky">
          <h4>üü° High Risk</h4>
          <ul>
            <li><strong>Tyramine-rich foods:</strong> Aged cheese, wine, cured meats</li>
            <li><strong>Caffeine:</strong> Increased stimulant effects</li>
            <li><strong>Alcohol:</strong> Unpredictable blood pressure effects</li>
            <li><strong>Opioids:</strong> Some combinations dangerous</li>
            <li><strong>Decongestants:</strong> Pseudoephedrine, phenylephrine</li>
          </ul>
        </div>
        
        <div class="interaction caution">
          <h4>üü† Avoid Completely</h4>
          <ul>
            <li><strong>All antidepressants:</strong> 2-week washout minimum</li>
            <li><strong>Anesthetics:</strong> Inform anesthesiologist of MAOI use</li>
            <li><strong>Blood pressure medications:</strong> Monitor carefully</li>
            <li><strong>Diabetes medications:</strong> May affect blood sugar</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section legal">
      <h3>‚öñÔ∏è Legal Status</h3>
      <div class="legal-info">
        <div class="legal-jurisdictions">
          <div class="jurisdiction">
            <h4>üá∫üá∏ United States</h4>
            <p><strong>Prescription Only</strong> - Pharmaceutical MAOIs are prescription medications. Natural sources like Syrian rue are legal to purchase and possess.</p>
          </div>
          <div class="jurisdiction">
            <h4>üá¨üáß United Kingdom</h4>
            <p><strong>Prescription Only Medicine</strong> - Pharmaceutical MAOIs require prescription. Natural sources generally legal.</p>
          </div>
          <div class="jurisdiction">
            <h4>üá®üá¶ Canada</h4>
            <p><strong>Prescription Required</strong> - All pharmaceutical MAOIs are controlled medications requiring medical supervision.</p>
          </div>
          <div class="jurisdiction">
            <h4>üá¶üá∫ Australia</h4>
            <p><strong>Schedule 4</strong> - Prescription only medicines with strict medical oversight required.</p>
          </div>
        </div>
        
        <div class="therapeutic-status">
          <h4>üè• Medical Applications</h4>
          <p>MAOIs remain FDA-approved for treatment-resistant depression, atypical depression, and certain anxiety disorders. Selegiline approved for Parkinson's disease. They're considered last-line treatments due to safety concerns but remain invaluable for patients who don't respond to other antidepressants.</p>
        </div>
      </div>
    </div>

    <div class="profile-section history">
      <h3>üìö History & Culture</h3>
      
      <div class="history-timeline">
        <div class="history-event">
          <span class="year">1951</span>
          <p>Iproniazid (anti-tuberculosis drug) discovered to have antidepressant effects</p>
        </div>
        <div class="history-event">
          <span class="year">1957</span>
          <p>First MAOIs approved for depression treatment</p>
        </div>
        <div class="history-event">
          <span class="year">1960s</span>
          <p>Widespread use until "cheese effect" hypertensive crises recognized</p>
        </div>
        <div class="history-event">
          <span class="year">1970s</span>
          <p>Use declined with introduction of safer tricyclic antidepressants</p>
        </div>
        <div class="history-event">
          <span class="year">1980s</span>
          <p>SSRIs further reduced MAOI prescribing</p>
        </div>
        <div class="history-event">
          <span class="year">1990s</span>
          <p>Revival for treatment-resistant depression cases</p>
        </div>
        <div class="history-event">
          <span class="year">2000s</span>
          <p>Selegiline patch approved, reducing dietary restrictions</p>
        </div>
        <div class="history-event">
          <span class="year">2010s</span>
          <p>Research into natural MAOIs for ayahuasca and DMT experiences</p>
        </div>
      </div>

      <div class="cultural-impact">
        <h4>Medical & Psychedelic Context</h4>
        <p>MAOIs represent both the promise and peril of psychiatric medicine - capable of profound therapeutic benefits but demanding extraordinary caution. In psychedelic contexts, natural MAOIs enable oral DMT experiences through ayahuasca, representing thousands of years of indigenous knowledge about these dangerous but powerful compounds.</p>
      </div>
    </div>

    <div class="profile-section research">
      <h3>üî¨ Current Research</h3>
      
      <div class="research-areas">
        <div class="research-item">
          <h4>Treatment-Resistant Depression</h4>
          <p>Ongoing studies comparing MAOI efficacy to modern treatments like ketamine and psilocybin for patients who don't respond to first-line antidepressants.</p>
        </div>
        
        <div class="research-item">
          <h4>Parkinson's Disease</h4>
          <p>Research into MAO-B inhibitors for neuroprotection and symptom management in neurodegenerative disorders.</p>
        </div>
        
        <div class="research-item">
          <h4>Atypical Depression</h4>
          <p>Studies examining MAOI effectiveness for depression with reverse neurovegetative symptoms (increased appetite, hypersomnia).</p>
        </div>
        
        <div class="research-item">
          <h4>Natural MAOI Safety</h4>
          <p>Research into standardization and safety protocols for plant-based MAOIs used in traditional medicine and psychedelic therapy.</p>
        </div>
        
        <div class="research-item">
          <h4>Reversible MAOIs</h4>
          <p>Development of safer, reversible MAOIs that don't require strict dietary restrictions while maintaining therapeutic efficacy.</p>
        </div>
      </div>
    </div>

  </div>

  <div class="substance-resources">
    <h3>üìñ Additional Resources</h3>
    <div class="resources-grid">
      <div class="resource-item">
        <h4>Medical Information</h4>
        <ul>
          <li><a href="https://www.mayoclinic.org/diseases-conditions/depression/in-depth/maois/art-20043992">Mayo Clinic MAOI Guide</a> - Comprehensive medical information</li>
          <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC181074/">NCBI MAOI Review</a> - Scientific literature</li>
          <li><strong>Consult psychiatrist:</strong> Always required for MAOI treatment</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Dietary Restrictions</h4>
        <ul>
          <li><a href="https://www.drugs.com/food-interactions/phenelzine.html">MAOI Food Interactions</a> - Complete dietary guidelines</li>
          <li><strong>Foods to avoid:</strong> Aged cheeses, wine, cured meats, soy products</li>
          <li><strong>Emergency protocol:</strong> Know symptoms of hypertensive crisis</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Support & Safety</h4>
        <ul>
          <li><a href="https://www.reddit.com/r/MAOIs/">/r/MAOIs</a> - Patient community support</li>
          <li><a href="https://www.psychforum.com/">PsychForum</a> - MAOI treatment discussions</li>
          <li><strong>Medical alert:</strong> Always carry MAOI identification</li>
        </ul>
      </div>
    </div>
  </div>

</div>
    </main>
     <div class="footer-divider"></div>
<footer class="site-footer">
  
</footer>




<footer class="site-footer">
  
  </svg>
    <img src="/assets/logo.svg" alt="My Logo" class="logo">
     <p>¬© 2025 Uwaniumnya. Highly Illegal.</p>
  </footer>

  

    <!-- Search Scripts -->
    <script src="/js/lunr.min.js"></script>
    <script src="/assets/js/search.js"></script>
    <script src="/assets/js/substance-integration.js"></script>
</body>
</html>